Julie H McHugh

Director

From 2004 to 2006 Ms. McHugh was president of Centocor, Inc., a J&J subsidiary, where she oversaw the development and launch of Remicade® (infliximab). From 2006 to 2008, she served as company group chairman for Johnson & Johnson's worldwide virology business unit, where she oversaw the launches of Prezista® (darunavir) and Intelence® (etravirine). Most recently she served as chief operating officer at Endo Health Solutions Inc. from 2010 to 2013. Prior to this, she served as chief executive officer of Nora Therapeutics, Inc., a private biotech company focused on developing novel therapies for the treatment of infertility disorders. Ms. McHugh currently serves on the board of directors of Ironwood Pharmaceuticals, Inc. and of EPIRUS Biopharmaceuticals Inc., both public pharmaceutical companies, and Xellia Pharmaceuticals, a private specialty pharmaceutical company.